Remove Microdosing Remove Research and Development Remove Treatment
article thumbnail

Exploring Microdosing: A Comprehensive Guide to Minimal Cannabis Consumption

United Patients Group

United Patients Group is dedicated to providing the latest information and research surrounding medical marijuana, empowering readers to make informed decisions about their health journey. In the sections that follow, we will delve deeper into the principles of microdosing medical marijuana.

article thumbnail

Press Release: PsiloThera, Inc. a Leader in Psychedelic Healthcare Innovation Announces the Filing of U. S. Patents Protecting Its Proprietary Psychedelic Therapeutic Process, Tele-Mental Healthcare & Microdosing Online Platform

Cannabis Law Report

is a pioneering Psychedelic Healthcare Innovation & Life Sciences Company in early stage development of Psilocybin (“Magic Mushroom”) based drugs and therapies proudly announces t he Filing of U. Patents Protecting Its Proprietary Psychedelic Therapeutic Process and Tele-Mental Health & Microdosing Platform.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A.I.-Designed Drugs to Advance Healthcare, Research & Treatment Options

NewsMunchies

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

article thumbnail

New Zealand Government Grants $650K For LSD Microdosing Trials

Cannabis Law Report

together with research collaborators at the University of Auckland , have received NZ$1.44 million ($650,000) in funding from New Zealand’s Health Research Council (HRC) to conduct a LSD microdosing trial in patients with Major Depressive Disorder (MDD). — MindBio Therapeutics (@MindBioTherap) July 10, 2022.

article thumbnail

Press Release: Origin Therapeutics Announces First Five Portfolio Companies

Cannabis Law Report

integrates the latest developments in neuroscience and neurobiology to create a novel approach to mental health and well-being. is focused on the development, production, and marketing of psychedelic-based products, as legally permitted, with clinically proven efficacy. Dimensions Health Centres Inc. Xpira Pharmaceuticals Inc.

article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders.

History 119
article thumbnail

Indiana Nurse Could Face A Decade In Prison For Microdosing Psilocybin Mushrooms

Cannabis Law Report

For Jessica Thornton, who has lived with treatment-resistant depression since her senior year at high school, psychedelics represent a lifeline. Desperate to find any solution, she tried microdosing psilocybin mushrooms after researching the practice online. I felt as if I was in a constant battle with myself. I was just numb.